Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors

Sanjay Adhikary a, Subrata Roy ab, Shailesh Budhathoki c, Siam Chowdhury ad, Abbey Stillwell a, Alexei G. Basnakian ef, Alan Tackett g, Nathan Avaritt g, Mohamed Milad h and Mohammad Abrar Alam *abci
aDepartment of Chemistry and Physics, College of Sciences and Mathematics, Arkansas State University, Jonesboro, Arkansas 72467, USA. E-mail: malam@astate.edu
bEnvironmental Sciences Program, College of Sciences and Mathematics, Arkansas State University, Jonesboro, AR 72467, USA
cMolecular Biosciences Program, College of Sciences and Mathematics, Arkansas State University, Jonesboro, AR 72467, USA
dComputer Science, The College of Engineering and Computer Science, Arkansas State University, Jonesboro, AR 72468, USA
eDepartment of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, 4301 W. Markham St, Little Rock, AR 72205, USA
fCentral Arkansas Veterans Healthcare System, W. 7th St, Little Rock, AR 72205, USA
gDepartment of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA
hThe Department of Mathematics and Statistics, Arkansas State University, Jonesboro, AR 72467, USA
iArkansas Biosciences Institute, Arkansas State University, Jonesboro, AR 72467, USA

Received 20th March 2025 , Accepted 20th March 2025

First published on 3rd April 2025


Abstract

Correction for ‘Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors’ by Sanjay Adhikary et al., RSC Med. Chem., 2025, 16, 1105–1130, https://doi.org/10.1039/d4md00719k.


The authors regret that the name displayed for compound E17 in the ‘Materials and methods’ section of their article contains an error. The corrected name for compound E17 is (1S,2R,13R,14S,17R,18S)-17-ethynyl-2,18-dimethyl-7-[(3-methyl-2-pyridyl)amino]-8-thia-6-azapentacyclo[11.7.0.02,10.05,9.014,18]icosa-5(9),6,10-trien-17-ol.

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.


This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.